Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children worldwide. But RSV doesn’t affect all children in the same way. In this article, pediatric pulmonologist Fabria Rezaee, MD, discusses her study that suggests air pollution may intensify RSV symptoms.
There are no FDA-approved drugs to treat kids who get RSV. Cleveland Clinic researchers published the results of a groundbreaking pediatric study, which may lead to better treatments.
A new study dissects the pathways involved in RSV-induced barrier disruption and examines how modifying the involved mechanisms could restore the barrier’s integrity.
Cross-placenta viral transmission during the first trimester of pregnancy contributes to the development of asthma and other chronic respiratory problems, and may explain other postnatal conditions.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Cleveland Clinic Children’s continues research into RSV with goal of improving understanding of basic biology and aiding in design of new agents.